hoperugo.bsky.social @hoperugo.bsky.social · 23/11/2024You are too funny but thanks for the kind words!! @sabcs.bsky.social is our opportunity to spread the word about @bsky.app 0141
hoperugo.bsky.social @hoperugo.bsky.social · 23/11/2024Great news - post #sabcs24 on bsky.social! This is the way to get our colleagues and friends on board. @sabcs.bsky.social @oncoalert.bsky.socialbsky.socialBlueskySocial media as it should be. Find your community among millions of users, unleash your creativity, and have some fun again. 1225
hoperugo.bsky.social @hoperugo.bsky.social · 23/11/2024We need to get the oncology community on board! Can’t deal with X!! 1152
hoperugo.bsky.social @hoperugo.bsky.social · 23/11/2024Have to share this beautiful photo. @oncoalert.bsky.social 2121
hoperugo.bsky.social @hoperugo.bsky.social · 23/11/2024Thanks for posting! A favorite activity is the recordings I do with Sara Tolaney around new data at our international meetings! @oncoalert.bsky.social @ucsfcancer.bsky.social 0259
hoperugo.bsky.social @hoperugo.bsky.social · 19/11/2024Impact of risk reducing surg for young women with BRCA (Lambertini). Zest (Turner) about ctDNA in high risk early stage disease, what have we learned! of course many more... @oncoalert.bsky.social 0156
hoperugo.bsky.social @hoperugo.bsky.social · 19/11/2024Agree with the list, big data coming up! - a few more here and to follow: COMET, important trial evaluating watch and wait vs surgery for low risk DCIS (Hwang). PADMA: RW study of Pablo/letrozole vs chemo for metastatic disease (Loibl). 0113
